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Joao Q. Melo, MD, PhD, Carnaxide, Portugal
952 Prosthesis–patient mismatch and clinical outcomes: The evidence continues
to accumulate 
Jean G. Dumesnil, MD, FRCP (C), FACC, and Philippe Pibarot, DVM, PhD, FACC,
Sainte-Foy, Quebec, Canada
Cardiopulmonary
Support and Physiology
(CSP)
956 Integrated coronary revascularization with drug-eluting stents: Immediate
and seven-month outcome
Thomas A. Vassiliades Jr, MD, John S. Douglas, MD, Douglas C. Morris, MD,
Peter C. Block, MD, Ziyad Ghazzal, MD, S. Tanveer Rab, MD, and Christopher U. Cates, MD,
Atlanta, Ga
Integrated coronary revascularization was performed in 47 patients combining minimally
invasive LITA to LAD with drug-eluting stent implantation of non-LAD lesions. Early clinical
outcome results showed no deaths, myocardial infarctions, or neurologic events, and a target
vessel revascularization rate for drug-eluting stent of 6.6%.
963 Fatal pulmonary microthrombi during surgical therapy for end-stage heart
failure: Possible association with antifibrinolytic therapy
John R. Cooper, Jr, MD, Jacki Abrams, MD, O. H. Frazier, MD, Rajko Radovancevic, MD,
Branislav Radovancevic, MD, Arthur W. Bracey, MD, Michel J. Kindo, MD, and
Igor D. Gregoric, MD, Houston, Tex
We have encountered fatal thrombotic complications in 9 patients with high pulmonary artery
pressures caused by pulmonary microthrombi after a cardiac surgical procedure for end-stage
heart failure. This study records and analyzes this fatal thrombotic complication in these
patients.
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969 Importance of endothelial nitric oxide synthase for the hypothermic
protection of lungs against ischemia-reperfusion injury
Li Zhang, MD, Sanjeev Kumar, BS, Alexander Kaminski, MD, Cornelius Kasch,
Christoph Sponholz, MD, Christof Stamm, MD, Yury Ladilov, PhD, and
Gustav Steinhoff, MD, Rostock, Germany
Protection against pulmonary I/R injury by mild intraischemic hypothermia is eNOS dependent
and is accompanied by up-regulation of eNOS expression and phosphorylation.
975 Restoration of myocardial -adrenergic receptor signaling after left
ventricular assist device support
Prakash K. Pandalai, MD, Christian F. Bulcao, MD, Walter H. Merrill, MD, and
Shahab A. Akhter, MD, Cincinnati, Ohio
Left ventricular assist device support for chronic heart failure (HF) can restore -adrenergic
receptor (AR) signaling, which has important implications in myocardial recovery. A primary
mechanism for this enhancement of signaling is inhibition of myocardial G protein–coupled
receptor kinase (GRK) 2 activity. Inhibition of GRK2 might represent an important therapeutic
approach for HF.
General Thoracic
Surgery (GTS)
981 The pattern of lymph node involvement influences outcome after
extrapleural pneumonectomy for malignant mesothelioma
John G. Edwards, PhD, FRCS, D. J. Stewart, FRCS, Antonio Martin-Ucar, FRCS,
Salli Muller, FRCPath, Cathy Richards, FRCPath, and David A. Waller, FRCS(CTh), Leicester,
United Kingdom
Lymphadenectomy specimens of 92 patients with malignant mesothelioma undergoing
extrapleural pneumonectomy were examined for skip metastases (42%), N2 nodes inaccessible
to mediastinoscopy (49%), and the false-negative mediastinoscopy rate (33%). Survival
predictors included N2 disease and the proportion of positive nodes but not skip metastases.
988 Clinicopathologic study of resected, peripheral, small-sized, non–small cell
lung cancer tumors of 2 cm or less in diameter: Pleural invasion and
increase of serum carcinoembryonic antigen level as predictors of nodal
involvement
Masayoshi Inoue, MD, Masato Minami, MD, Hiroyuki Shiono, MD, Noriyoshi Sawabata, MD,
Kan Ideguchi, MD, and Meinoshin Okumura, MD, Osaka, Japan
Nodal metastases should be considered in patients with non–small cell lung cancer of 2 cm or
less in diameter showing pleural invasion or an increased carcinoembryonic antigen level. We
recommend a lobectomy plus node dissection for patients with a tumor larger than 1.5 cm,
suspected pleural invasion, or prethoracotomy carcinoembryonic antigen level increase.
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994 Breath-hold single-photon emission tomography and computed tomography
for predicting residual pulmonary function in patients with lung cancer
Manabu Sudoh, MD, Kazuhiro Ueda, MD, Yoshikazu Kaneda, MD, Jinbo Mitsutaka, MD,
Tao-Sheng Li, MD, Kazuyoshi Suga, MD, Yasuhiko Kawakami, MD, and
Kimikazu Hamano, MD, Yamaguchi, Japan
The residual pulmonary function predicted by using single-photon emission tomography and
computed tomography (SPET/CT) correlated well with that predicted by means of segment
counting. However, the values were significantly underestimated by the segment counting in
patients with severe emphysema. SPET/CT might be indispensable in patients with severe
emphysema and borderline lung function.
1002 Biologic effects of radiofrequency thermal ablation on non–small cell lung
cancer: Results of a pilot study
Marcello Carlo Ambrogi, MD, Gabriella Fontanini, MD, Roberto Cioni, MD,
Pinuccia Faviana, MD, Olivia Fanucchi, MD, and Alfredo Mussi, MD, Pisa, Italy
Radiofrequency ablation of lung tumors is an emerging technique, and the preliminary results
seem promising. We report 2 “ablate and resect” protocols that allow analysis of the biologic
effects of the procedure on the lung parenchyma and its tumors.
1007 Percutaneous cryoablation of small pulmonary malignant tumors under
computed tomographic guidance with local anesthesia for nonsurgical
candidates
Masafumi Kawamura, MD, Yotaro Izumi, MD, Norimasa Tsukada, MD, Keisuke Asakura, MD,
Hiroaki Sugiura, MD, Hideki Yashiro, MD, Keiko Nakano, MD, Seishi Nakatsuka, MD,
Sachio Kuribayashi, MD, and Koichi Kobayashi, MD, Tokyo, Japan
Percutaneous cryoablation therapy is an alternative to wedge resection, stereotactic
radiotherapy, or radiofrequency ablation therapy for local control of metastatic lung tumors.
1014 Histologic grade is an independent prognostic factor for survival in
non–small cell lung cancer: An analysis of 5018 hospital- and
712 population-based cases
Zhifu Sun, MD, MS, Marie-Christine Aubry, MD, Claude Deschamps, MD,
Randolph S. Marks, MD, Scott H. Okuno, MD, Brent A. Williams, MS, Hiroshi Sugimura, MD,
V. Shane Pankratz, PhD, and Ping Yang, MD, PhD, Rochester, Minn
Histologic grade has been demonstrated as a significant prognostic factor for NSCLC from an
analysis of 5018 hospital- and 712 population-based cases. The prognostic effect is independent
of age, gender, smoking history, tumor stage, histologic cell type, and treatment modality.
Surgery for Acquired
Cardiovascular Disease
(ACD)
1021 How many arterial grafts are enough? A population-based study of midterm
outcomes ■
Veena Guru, MD, Stephen E. Fremes, MD, MSc, and Jack V. Tu, MD, PhD, Toronto, Ontario,
Canada
This study compares the use and outcomes of 1, 2, or 3 arterial CABGs at a population level in
Ontario (1991-2001). Two or 3 arterial grafts provide a benefit in low-, moderate-, and high-
risk patients, including lower rates of cardiac readmission (HR, 0.8) and mortality (HR, 0.8)
after surgical intervention, compared with 1 arterial graft.
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1029 Surgical ablation as treatment for the elimination of atrial fibrillation:
A meta-analysis ●
Scott D. Barnett, PhD, and Niv Ad, MD, Falls Church, Va
Our meta-analysis suggests biatrial ablation surgical procedures were more effective in
controlling atrial fibrillation than procedures confined to the left atrium.
1036 Prosthesis–patient mismatch after aortic valve replacement predominantly
affects patients with preexisting left ventricular dysfunction: Effect on
survival, freedom from heart failure, and left ventricular mass regression 
Marc Ruel, MD, MPH, Hussam Al-Faleh, MD, Alexander Kulik, MD, Kwan L. Chan, MD,
Thierry G. Mesana, MD, PhD, and Ian G. Burwash, MD, Ottawa, Ontario, Canada
The long-term clinical and echocardiographic effects of patient-prosthesis mismatch were
examined in 805 patients with and without LV systolic dysfunction at the time of AVR.
Patients with impaired preoperative LV function and mismatch had lower survival, freedom
from heart failure, and LV mass regression compared with patients with impaired preoperative
LV function and no mismatch. These effects of mismatch were not observed in patients with
normal preoperative LV function. Patients with impaired LV function at the time of AVR
therefore represent a critical population in whom mismatch should be avoided.
1045 A single nucleotide polymorphism in the matrix metalloproteinase 9 gene
(8202A/G) is associated with thoracic aortic aneurysms and thoracic aortic
dissection
Li Chen, PhD, Xinwen Wang, MD, PhD, Stacey A. Carter, BA, Ying H. Shen, MD, PhD,
Heather R. Bartsch, MS, Robert W. Thompson, MD, Joseph S. Coselli, MD,
David L. Wilcken, MD, Xing Li Wang, MD, PhD, and Scott A. LeMaire, MD, Houston, Tex,
St Louis, Mo, and Sydney, Australia
The frequency distributions of 3 single nucleotide polymorphisms in the matrix
metalloproteinase 9 gene were determined in 85 patients with thoracic aortic disease and 111
control subjects. Patients with aortic dissection or degenerative thoracic aortic aneurysms were
nearly 5 times more likely than control subjects to carry the G allele of the 8202A/G
polymorphism.
1053 Immediate endovascular treatment of blunt aortic injury: Our therapeutic
strategy
Andrea Agostinelli, MD, Stefano Saccani, MD, Bruno Borrello, MD, Francesco Nicolini, MD,
Pietro Larini, MD, and Tiziano Gherli, MD, Parma, Italy
Acute posttraumatic aortic rupture is a lethal injury and usually occurs in patients with severe
polytrauma and multiple lesions. Timing of the treatment is still controversial. The aim of the
present study is to evaluate the short- and medium-term result of our therapeutic strategy
consisting of immediate endovascular treatment.
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1058 Small aortic annulus: The hydrodynamic performances of 5 commercially
available tissue valves
Gino Gerosa, MD, Vincenzo Tarzia, MD, Giulio Rizzoli, MD, and Tomaso Bottio, MD, PhD,
Padova and Brescia, Italy
Management of patients with a small aortic annulus is challenging. It has been recommended
that the indexed effective orifice area should be larger than 0.85 cm2/m2 to improve the
patient’s functional capacity and quality of life. Continuous refinements of valve prosthesis
design would probably solve the problem, minimizing rest and exercise gradients. However,
in vivo comparisons between different prostheses are difficult and misleading. Assuming a
correspondence with the in vivo behavior, this in vitro study, performed on 5 different supra-
annular tissue valves comparable in terms of tissue annulus diameter regardless of the labeled
manufacturer’s size, can be helpful in assisting surgical decision making.
1065 Pharmacologic inhibition of vein graft neointimal hyperplasia
Thomas Schachner, MD, Innsbruck, Austria
Despite the important use of arterial conduits, vein grafts remain important in coronary artery
bypass grafting. One way to increase their longevity is local or systemic pharmacotherapeutic
intervention, which is reviewed in this article.
1073 Impact of follow-up on the success rate of the cryosurgical maze procedure
in patients with rheumatic heart disease and enlarged atria
Niv Ad, MD, Scott Barnett, PhD, Edward A. Lefrak, MD, Amit Korach, MD,
Arthur Pollak, MD, Dan Gilon, MD, and Amir Elami, MD, Falls Church, Va, and Jerusalem,
Israel
Fifty-five patients with atrial fibrillation and at least 1 significant predictor for failure of the
maze procedure were enrolled in this study. Late recurrences of arrhythmia were treated
successfully with antiarrhythmic drugs and/or cardioversion.
1080 Biventricular diastolic filling patterns after coronary artery bypass graft
surgery
Yanfen Shi, MD, Andre´ Y. Denault, MD, Pierre Couture, MD, Ady Butnaru, MD,
Michel Carrier, MD, and Jean-Claude Tardif, MD, FACC, Montreal, Quebec, Canada
The evolution of biventricular filling as defined with newer echocardiographic modalities after
coronary artery bypass grafting is unknown, as is the effect of milrinone. Transthoracic
echocardiography was done preoperatively and 48 hours and 6 months postoperatively in 49
patients (milrinone, 25 patients; placebo, 24 patients). Biventricular filling deteriorated at 48
hours and returned to baseline values at 6 months, with no effect of milrinone on this
evolution.
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1087 Thoracic aortic stent grafting: Improving results with newer generation
investigational devices
Jehangir J. Appoo, MD, William G. Moser, RN, Ronald M. Fairman, MD,
Katherine F. Cornelius, RN, A. Pochettino, MD, Edward Y. Woo, MD, Jibby E. Kurichi, MPH,
Jefferey P. Carpenter, MD, and Joseph E. Bavaria, MD, Philadelphia, Pa
A single-center experience with 99 descending thoracic aortic stent grafts revealed improved
results with newer devices. On the basis of these data, results should improve as device designs
improve.
1095 Comparison of Coapsys annuloplasty and internal reduction mitral
annuloplasty in the randomized treatment of functional ischemic mitral
regurgitation: Impact on the left ventricle
E. A. Grossi, MD, Y. J. Woo, MD, C. F. Schwartz, MD, D. M. Gangahar, MD,
V. A. Subramanian, MD, N. Patel, MD, J. Wudel, MD, P. L. DiGiorgi, MD, A. Singh, MD, and
R. D. Davis, MD, New York, NY, Philadelphia, Pa, Omaha and Lincoln, Neb, Providence, RI,
and Durham, NC
Acute effects of aggressive reduction mitral annuloplasty and Coapsys annuloplasty on
ventricular shape were compared. Both techniques reduced functional mitral insufficiency and
annular dimensions. Only Coapsys annuloplasty provided acute significant LV reshaping as
measured by LV diameters and sphericity indices.
Surgery for Congenital
Heart Disease (CHD)
1099 Inclusion of oxygen consumption improves the accuracy of arterial and
venous oxygen saturation interpretation after the Norwood procedure
Jia Li, MD, PhD, Gencheng Zhang, MD, PhD, Helen M. Holtby, MBBS,
Brian W. McCrindle, MD, MPH, Sally Cai, PhD, Tilman Humpl, MD,
Christopher A. Caldarone, MD, William G. Williams, MD, Andrew N. Redington, MD, and
Glen S. Van Arsdell, MD, Toronto, Ontario, Canada
Indirect indicators of systemic venous saturation, arterial venous saturation difference, and
oxygen excess factor showed a close correlation with oxygen extraction ratio. Correlation with
systemic cardiac output and oxygen delivery was improved by accounting for systemic oxygen
consumption, which may allow for a more accurately targeted postoperative management
strategy.
1108 Contemporary management of right atrial isomerism: Effect of evolving
therapeutic strategies
Tae-Jin Yun, MD, Osman O. Al-Radi, MD, Ian Adatia, MD, Christopher A. Caldarone, MD,
John G. Coles, MD, William G. Williams, MD, Jeffrey Smallhorn, MD, and
Glen S. Van Arsdell, MD, Ulsan, Republic of Korea, Toronto, Canada, and San Francisco,
Calif
Current surgical strategy for right atrial isomerism has resulted in improved survival through
improved perioperative support and primary sutureless repair of total anomalous pulmonary
venous drainage (TAPVD). Patients having infracardiac or mixed-type TAPVD or those with
obstruction to pulmonary venous drainage are at higher risk of death.
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1114 Extracorporeal life support after staged palliation of a functional single
ventricle: Subsequent morbidity and survival
Aparna Hoskote, MD, Desmond Bohn, MB, BCh, Colleen Gruenwald, CCP,
David Edgell, CCP, Sally Cai, MSc, Ian Adatia, MB, ChB, and Glen Van Arsdell, MD,
Toronto, Canada
Twenty-five infants with functional single ventricle were supported with postoperative
extracorporeal life support, 20% with a ventricular assist device (VAD), and 50% converted
from extracorporeal membrane oxygenation to a VAD. Survival to decannulation was 76%, and
survival to hospital discharge was 44%.
1122 Impact of preoperative treatment strategies on the early perioperative
outcome in neonates with hypoplastic left heart syndrome
Ju¨rgen Stieh, MD, Gunther Fischer, MD, Jens Scheewe, MD, Anselm Uebing, MD,
Peter Du¨tschke, MD, Olaf Jung, MD, Ralph Grabitz, MD, Hans Joachim Trampisch, PhD, and
Hans Heiner Kramer, MD, Kiel and Bochum, Germany
In neonates with HLHS, systemic afterload reduction can avoid preoperative artificial
respiration, identified as a significant risk factor for preoperative dysfunction of end organs and
in-hospital death, thus not only making intensive care much easier but probably exerting a
positive effect on overall outcome.
1130 Off-label use of an adjustable gastric banding system for pulmonary artery
banding
Younes Boudjemline, MD, Emmanuelle Pineau, MD, Caroline Bonnet, MD, Alix Mollet, MD,
Sylvia Abadir, MD, Damien Bonnet, MD, Daniel Sidi, MD, and Gabriella Agnoletti, MD, Paris,
Le Plessis Robinson, and Dijon, France
Pulmonary artery banding may be used in infants with conplex congenital heart disease and
increased pulmonary blood flow, and to retrain the left ventricle in corrected transposition of
the great arteries. We report the off-label use of an adjustable gastric banding system of
pulmonary artery banding in animals.
1136 Surgical management of aortopulmonary window associated with
interrupted aortic arch: A Congenital Heart Surgeons Society study
Igor E. Konstantinov, MD, PhD, Tara Karamlou, MD, William G. Williams, MD,
Jan M. Quaegebeur, MD, Pedro J. del Nido, MD, Thomas L. Spray, MD,
Christopher A. Caldarone, MD, Eugene H. Blackstone, MD, and
Brian W. McCrindle, MD, MPH, for the members of the Congenital Heart Surgeons Society,
Toronto, Canada, New York, NY, Boston, Mass, Philadelphia, Pa, and Cleveland, Ohio
We describe outcomes in infants with complex aortopulmonary window (APW). Complete
neonatal correction of APW associated with interrupted aortic arch (IAA) can be performed
with low mortality, but reinterventions are common. Patch augmentation of the IAA
anastomosis reduces the risk of subsequent arch obstruction and the development of bronchial
compression.
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Cardiothoracic
Transplantation (TX)
1142 Living donor lobar grafts improve pediatric lung retransplantation survival
Benjamin D. Kozower, MD, Stuart C. Sweet, MD, Maite de la Morena, MD,
Pamela Schuler, MD, Tracey J. Guthrie, BSN, G. Alexander Patterson, MD,
Sanjiv K. Gandhi, MD, and Charles B. Huddleston, MD, St. Louis, Mo
Living donor lobar lung grafts improve survival following pediatric lung retransplantation and
preserve the limited supply of cadaveric lungs for other children waiting for transplantation.
1148 Lung regeneration: Implantation of fetal rat lung fragments into adult rat
lung parenchyma
Koichiro Kenzaki, MD, Shoji Sakiyama, MD, PhD, Kazuya Kondo, MD, PhD,
Mitsuteru Yoshida, MD, Yukikiyo Kawakami, MD, Masatsugu Takehisa, MD,
Hiromitsu Takizawa, MD, Takanori Miyoshi, MD, PhD, Yoshimi Bando, MD, PhD,
Akira Tangoku, MD, PhD, and Mingyao Liu, MD, PhD, Tokushima, Japan, and Toronto,
Ontario, Canada
Fetal lung tissues are organs with great potential for growth and differentiation. The fetal lung
grafts implanted into pulmonary parenchyma were differentiated with opening of the alveolar
space and connected with pulmonary circulation. We consider that fetal lung tissue might be an
option for further investigation into lung regeneration.
1154 Extended donor criteria in lung transplantation: Impact on organ allocation
Phil Botha, MRCS, Dipesh Trivedi, FRCS, Christopher J. Weir, PhD, Cait P. Searl, FRCA,
Paul A. Corris, FRCP, John H. Dark, FRCS, and Stephan V. B. Schueler, FRCS, Newcastle
upon Tyne and Glasgow, United Kingdom
We present a single-institution experience of the allocation of extended criteria donor organs in
lung transplantation. A higher organ-specific mortality rate in the short term, especially with
bilateral transplantation using marginal organs, is demonstrated. Longer-term outcome appears
similar, with no higher incidence of early bronchiolitis obliterans syndrome.
1161 Clopidogrel reduces the development of transplant arteriosclerosis
Silke Abele, Michael Weyand, MD, Martina Wollin, Nicola E. Hiemann, MD,
Frank Harig, MD, Teddy Fischlein, MD, and Stephan M. Ensminger, MD, DPhil, Erlangen and
Berlin, Germany
The aim of this study was to investigate whether platelet inhibition has a positive effect on the
development of transplant arteriosclerosis in an experimental model of abdominal aortic
transplantation. Treatment with clopidogrel significantly reduced transplant arteriosclerosis
compared with that seen in control animals. These results demonstrate that clopidogrel can
effectively reduce the formation of transplant arteriosclerosis.
Brief Communications e7 Incidence and outcome of cardiopulmonary resuscitation in patients with
shunted single ventricle: Advantage of right ventricle to pulmonary artery
shunt
Eric M. Graham, MD, Geoffrey A. Forbus, MD, Scott M. Bradley, MD,
Girish S. Shirali, MBBS, and Andrew M. Atz, MD, Charleston, SC
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1167 Surgical repair of a large coronary artery aneurysm with arteriovenous
fistula
Pankaj Saxena, MCh, DNB, Igor E. Konstantinov, MD, PhD, Darryl Burstow, FRACP, and
Robert Tam, FRACS, Brisbane, Queensland, Australia
1169 Two distinct clinical presentations in adult unicuspid aortic valve
Arvind K. Agnihotri, MD, Shaun C. Desai, BA, Yong-Qiang Lai, MD,
Michael G. Fitzsimons, MD, FCCP, Alan D. Hilgenberg, MD, and Gus J. Vlahakes, MD,
Boston, Mass
1171 Thromboembolism from the noncoronary cusp of a patient with a normal
aortic valve and protein C deficiency
Shunya Shindo, MD, Kenji Kubota, MD, and Masahiko Matsumoto, MD, Yamanashi, Japan
1173 Lower extremity compartment syndrome after off-pump aortocoronary
bypass
Karthik R. Vaidyanathan, MS, Thiagarajamurthy Sundaramoorthi, FRCS (CTS),
Jagannath Raghavendrarao Byalal, DNB (CTS), Ganapathy Subramaniam Krishnan, MCh,
Madhu N. Sankar, DNB (CTS) PhD, Sanjay M. Cherian, MS, and
Kotturathu Mammen Cherian, FRACS, Mogappair, India
1174 Polydioxane (PDS) cord has insufficient reliability to securely close the
sternum
Akihiko Usui, MD, Hideki Oshima, MD, Toshiaki Akita, MD, and Yuichi Ueda, MD, Nagoya,
Japan
1175 Intraoperative finding of structural abnormality of bovine pericardial aortic
prosthesis
Uberto Da Col, MD, Davide Di Lazzaro, MD, Gino Di Manici, MD, Isidoro Di Bella, MD, and
Temistocle Ragni, MD, Perugia, Italy
1177 Valve-sparing excision of aortic valve papillary fibroelastoma
Parsia A. Vagefi, MD, Nathan R. Bates, MD, Leon M. Ptaszek, MD, PhD,
Mark S. Adams, RDCS, and Jennifer D. Walker, MD, Boston, Mass
1179 Pulmonary artery myxoma as a rare cause of dyspnea for a young female
patient
Shu-Chien Huang, MD, Meng-Lin Lee, MD, Shyh-Jye Chen, MD, Mu-Zon Wu, MD, and
Chung-I Chang, MD, Taipei, Taiwan
1181 Fungal prosthetic mitral valve endocarditis caused by Scopulariopsis species:
Case report and review of the literature
Alice May B. Isidro, MS, Valerianna Amorosa, MD, Gary A. Stopyra, MD,
Harold L. Rutenberg, MD, William H. Pentz, MD, and Charles R. Bridges, MD, ScD,
Philadelphia, Pa
1183 Erosion of a retroesophageal subclavian artery by an esophageal prosthesis
Fre´de´ric Vanden Eynden, MD, Jacques Deviere, MD, PhD, Marc Laureys, MD, and
Didier de Canniere, MD, PhD, Brussels, Belgium
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1185 Transaortic correction of tetralogy of Fallot and similar defects
Arkalgud Sampath Kumar, MCh, Sachin Talwar, MCh, and Devagourou Velayoudam, MCh,
New Delhi, India
1187 Aneurysmal sac located between right pulmonary artery and left atrium
Aysenur Pac, MD, Ugursay Kiziltepe, MD, Ozcan Ozeke, MD, Zehra Golbasi, MD, and
Mustafa Pac, MD, Ankara, Turkey
1188 Use of the endoclamp device in a patient with a native mitral valve
endocarditis and a previous arch replacement with a modified Griepp
technique
Siamak Mohammadi, Pierre Voisine, Patrick Mathieu, and François Dagenais, Que´bec City,
Canada
1190 Ventricular assist device use for the treatment of acute viral myocarditis
Veli K. Topkara, MD, Nicholas C. Dang, MD, Fabio Barili, MD, Timothy P. Martens, MD,
Isaac George, MD, Faisal H. Cheema, MD, Hasmet Bardakci, MD, Ali V. Ozcan, MD, and
Yoshifumi Naka, MD, PhD, New York, NY
1192 Off-pump pulmonary valve replacement with the new Shelhigh Injectable
Stented Pulmonic Valve
Pascal A. Berdat, MD, and Thierry Carrel, MD, Bern, Switzerland
1194 Transapical aortic valve implantation in humans Œ
Jian Ye, MD, Anson Cheung, MD, Samuel V. Lichtenstein, MD, PhD, Ronald G. Carere, MD,
Christopher R. Thompson, MD, Sanjeewan Pasupati, MD, and John G. Webb, MD, Vancouver,
BC, Canada
1196 Nourishing vascularization of a thymoma issued from a left internal thoracic
artery graft
Pascal A. Thomas, MD, Fre´de´ric Collart, MD, Christophe Doddoli, MD, Vlad Gariboldi, MD,
and Guy Moulin, MD, Marseille, France
1198 Giant gastrointestinal stromal tumor of the esophagus presenting with
dyspnea
Ahmet Basoglu, MD, Ekrem Kaya, MD, Burain Celık, MD, and Levent Yıldız, MD, Samsun and
Bursa, Turkey
1200 Stenotic bridging bronchus: A very rare entity
Salih Topcu, MD, Serife Tuba Liman, MD, Hasan Tahsin Sarisoy, MD,
Abdulkadir Babaoglu, MD, and Emre Ozker, MD, Kocaeli, Turkey
1202 Aseptic mediastinal cyst caused by BioGlue 7 months after cardiac surgery
A. Szafranek, MD, S. R. Podila, FRCS, W. Al-Khyatt, MD, and E. N. Kulatilake, FRCS, Cardiff,
United Kingdom
1204 Hiatal herniation of the pancreas: Diagnosis and surgical management
Pankaj Saxena, MCh, DNB, Igor E. Konstantinov, MD, PhD, Miriam D. Koniuszko, MBBS,
Soumya Ghosh, MBBS, PhD, Vincent H. S. Low, MBBS, FRANZCR, and
Mark A. J. Newman, MD, FRACS, Nedlands, Western Australia, Australia
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1205 Duropleural fistula as a consequence of Gorham-Stout syndrome:
A combination of 2 rare conditions
Ritwick Agrawal, MD, Imran Mohammed, MD, and Patrick G. Reilly, MD, Pittsburgh, Pa
1207 Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and a typical
carcinoid tumor
Elizabeth Chittilappilly Johney, MD, Joachim Pfannschmidt, MD, Ralf Joachim Rieker, MD,
Philipp Albert Schnabel, MD, PhD, Gunhild Mechtersheimer, MD, PhD, and
Hendrik Dienemann, MD, PhD, Heidelberg, Germany
Letters to the Editor 1209 Spondyloarthropathies and aortic dissection
Antonio Juan, MD, and Inmaculada Ros, MD, Baleares, Spain
1210 Reply
Hisato Takagi, MD, PhD, Seishiro Sekino, MD, and Takuya Umemoto, MD, PhD, Shizuoka, Japan
1210 Implantable cardioverter-defibrillator after left ventricular reconstruction?
Ulrik Sartipy, MD, Anders Albåge, MD, PhD, and Dan Lindblom, MD, PhD, Stockholm, Sweden
1211 Reply
Mina K. Chung, MD, and James O. O’Neill, MD, FRCPI, Cleveland, Ohio
1211 Left ventricular assist device in heart failure
Omer Ashraf, MBBS, Karachi, Pakistan
1212 Reply
Nicholas C. Dang, MD, and Yoshifumi Naka, MD, PhD, New York, NY
1212 Apoptosis in ischemic spinal cord injury
Koray Ak, Atike Tekeli, and Selim Isbir, Istanbul, Turkey
1213 Reply
Kazuchika Suzuki, MD, Teruhisa Kazui, MD, PhD, and
Abul Hasan Muhammad Bashar, MBBS, PhD, Hamamatsu, Japan
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